SIX MONTHS CSII TREATMENT IMPROVES ARTERIAL STIFFNESS AND ENDOTHELIAL GLYCOCALYX VS MDI INTENSIFICATION IN PATIENTS WITH TYPE 1 DIABETES INDEPENDENTLY OF GLYCEMIC CONTROL.

被引：0
|
作者：
Kountouri, A. [1 ]
Thymis, J. [2 ]
Kousathana, F. [1 ]
Balampanis, K. [1 ]
Pliouta, L. [1 ]
Prentza, V. [1 ]
Katogiannis, K. [2 ]
Kostelli, G. [2 ]
Barmpagianni, A. [3 ]
Liatis, S. [3 ]
Ikonomidis, I. [2 ]
Lambadiari, V. [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med 2, Sch Med, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Cardiol 2, Sch Med, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Dept Propaedeut & Internal Med 1, Sch Med, Athens, Greece
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P201 / #3
引用
收藏
页码：A153 / A153
页数：1
相关论文
共 35 条
  • [21] Treatment Intensification and A1c Change among Patients with Type 2 Diabetes and Poor Glycemic Control
    Fu, Alex Z.
    Sheehan, John
    DIABETES, 2016, 65 : A398 - A398
  • [22] GLP-1 for six weeks reduces weight and improves insulin sensitivity and glycemic control in patients with type 2 diabetes
    Zander, M
    Madsbad, S
    Holst, JJ
    DIABETES, 2001, 50 : A31 - A31
  • [23] The prolonged use of continuous measurement of glucose improves glycemic control in patients with type 1 diabetes in treatment intensifies
    Hanaire, H.
    Melki, V.
    Monelle, B.
    Schaepelynck, P.
    Riveline, J. -P.
    Chaillous, L.
    Renard, E.
    Sola, A.
    Penfornis, A.
    Tubiana-Rufi, N.
    Sulmont, V.
    Charpentier, G.
    DIABETES & METABOLISM, 2011, 37 : A13 - A13
  • [24] Change in HbA1c associated with treatment intensification among patients with type 2 diabetes and poor glycemic control
    Fu, Alex Z.
    Sheehan, John J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (05) : 853 - 858
  • [25] Once-daily insulin detemir improves glycemic control and tolerability in patients with type 1 or type 2 diabetes enrolled for 6 months in the PREDICTIVE™ study
    Dornhorst, Anne
    Sreenan, Seamus
    Ackermann, Ralf W.
    Hansen, Jes B.
    DIABETES, 2008, 57 : A583 - A584
  • [26] Enhanced external counterpulsation (EECP) improves biomarkers of glycemic control in patients with non-insulin-dependent type II diabetes mellitus for up to 3 months following treatment
    Paloma D. Sardina
    Jeffrey S. Martin
    Joseph C. Avery
    Randy W. Braith
    Acta Diabetologica, 2016, 53 : 745 - 752
  • [27] Enhanced external counterpulsation (EECP) improves biomarkers of glycemic control in patients with non-insulin-dependent type II diabetes mellitus for up to 3 months following treatment
    Sardina, Paloma D.
    Martin, Jeffrey S.
    Avery, Joseph C.
    Braith, Randy W.
    ACTA DIABETOLOGICA, 2016, 53 (05) : 745 - 752
  • [28] Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial
    Santi, Daniele
    Granata, Antonio R. M.
    Guidi, Alessandro
    Pignatti, Elisa
    Trenti, Tommaso
    Roli, Laura
    Bozic, Roberto
    Zaza, Stefano
    Pacchioni, Chiara
    Romano, Stefania
    Nofer, Jerzy Roch
    Rochira, Vincenzo
    Carani, Cesare
    Simoni, Manuela
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2016, 174 (04) : 513 - 522
  • [29] Re: Six Months of Daily Treatment with Vardenafil Improves Parameters of Endothelial Inflammation and of Hypogonadism in Male Patients with Type 2 Diabetes and Erectile Dysfunction: A Randomized, Double-Blind, Prospective Trial Editorial Comment
    Seftel, Allen D.
    JOURNAL OF UROLOGY, 2016, 196 (02): : 518 - 519
  • [30] Long-Term Glycemic Control in Patients with Long-Standing (>20 Years) Type 1 Diabetes Mellitus: Combined Islet Transplantation vs Intensive Insulin Treatment
    Locher, Rebecca
    Gerber, Philipp A.
    Zuellig, Richard A.
    Pfammatter, Thomas
    Wuethrich, Rudolf
    Spinas, Giatgen A.
    Lehmann, Roger
    DIABETES, 2010, 59 : A38 - A38
1234